Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea. (2017)
Attributed to:
Personalised management of atypical haemolytic uraemic syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/ckj/sfx081
PubMed Identifier: 28980670
Publication URI: http://europepmc.org/abstract/MED/28980670
Type: Journal Article/Review
Volume: 10
Parent Publication: Clinical kidney journal
Issue: 5
ISSN: 2048-8505